Henriques, L., 		Acurcio, F., 		Camelo, R., 		Barbosa, M., 		Guerra Júnior, A., & 		Alvares-Teodoro, J.
(2025).
 Cost-effectiveness analysis of prophylaxis with emicizumab or bypassing agents in children with severe haemophilia A and high-response inhibitors after immunotolerance failure in Brazil.
<em>Medical Research Archives, 13</em>(5).
doi:10.18103/mra.v13i5.6546